67 results
Page 2 of 4
6-K/A
EX-99.2
alegqyl5ol8 zpwm
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.5
evz5lk xx2n6f
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.5
f4fwjy8ooqxsli
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.2
fmixpqut9 7e4a1vl2
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
6kp0a5
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
6-K
EX-4.1
c1g3k
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-1.1
flocufy1fymfikcm
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-4.2
d06qxbbw3no6movnfyph
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
UPLOAD
gvnlz y7z90
8 Aug 19
Letter from SEC
12:00am
F-3
EX-4.2
erw22iqhzlk3zgoone
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
EX-4.5
301a7 5ejmtay7w
7 Aug 19
Shelf registration (foreign)
8:24am